NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Tegna Inc.
(NYSE:TGNA), Inpixon (NASDAQ:INPX), Honeywell International Inc. (NYSE:HON), Nektar Therapeutics (NASDAQ:NKTR), PDL Biopharma, Inc.
(NASDAQ:PDLI), and Innoviva, Inc. (NASDAQ:INVA) including updated fundamental summaries, consolidated fiscal reporting, and
fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
TGNA DOWNLOAD: http://Fundamental-Markets.com/register/?so=TGNA
INPX DOWNLOAD: http://Fundamental-Markets.com/register/?so=INPX
HON DOWNLOAD: http://Fundamental-Markets.com/register/?so=HON
NKTR DOWNLOAD: http://Fundamental-Markets.com/register/?so=NKTR
PDLI DOWNLOAD: http://Fundamental-Markets.com/register/?so=PDLI
INVA DOWNLOAD: http://Fundamental-Markets.com/register/?so=INVA
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Tegna
Inc. (NYSE:TGNA), Inpixon (NASDAQ:INPX), Honeywell International Inc. (NYSE:HON), Nektar Therapeutics (NASDAQ:NKTR), PDL Biopharma,
Inc. (NASDAQ:PDLI), and Innoviva, Inc. (NASDAQ:INVA) on a fundamental level and outlines the overall demand for their products and
services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward.
Several excerpts from the recently released reports are available to today’s readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. All information in this
release was accessed November 8, 2017. Please download the entire research report, free of charge, to ensure you are reading all
relevant material information. All amounts in millions (except per share amounts).
-----------------------------------------
TEGNA INC. (TGNA) REPORT OVERVIEW
Tegna's Recent Financial Performance
For the three months ended June 30, 2017 vs June 30, 2016 Tegna reported revenue of $489.4 vs $477.0 (up 2.6%),
diluted earnings per share -$0.60 vs $0.45, and dividends per share $0.07 vs $0.14 (down 50.0%). For the twelve months ended
December 31, 2016 vs December 31, 2015, Tegna reported revenue of $3,341.2 vs $3,051.0 (up 9.5%), diluted earnings per share $1.99
vs $2.00 (down 0.5%), and dividends per share $0.56 vs $0.68 (down 17.7%).
To read the full Tegna Inc. (TGNA) report, download it here: http://Fundamental-Markets.com/register/?so=TGNA
-----------------------------------------
INPIXON (INPX) REPORT OVERVIEW
Inpixon's Recent Financial Performance
For the three months ended June 30, 2017 vs June 30, 2016, Inpixon reported revenue of $15.1 vs $13.3 (up 13.5%)
and diluted earnings per share -$2.72 vs -$2.49. For the twelve months ended December 31, 2016 vs December 31, 2015, Inpixon
reported revenue of $53.2 vs $67.0 (down 20.6%) and diluted earnings per share -$15.61 vs -$8.30. Inpixon is expected to report
earnings on 11/13/2017. According to Zacks Investment Research, based on 1 analyst forecasts, the consensus EPS forecast for the
quarter is -$1.31. The reported EPS for the same quarter last year was -$2.10.
To read the full Inpixon (INPX) report, download it here: http://Fundamental-Markets.com/register/?so=INPX
-----------------------------------------
HONEYWELL INTERNATIONAL INC. (HON) REPORT OVERVIEW
Honeywell International's Recent Financial Performance
For the three months ended September 30, 2017 vs September 30, 2016, Honeywell International reported revenue of
$10,121 vs $9,804 (up 3.2%), diluted earnings per share $1.75 vs $1.60 (up 9.4%), and dividends per share $0.6650 vs $0.5950 (up
11.8%). For the twelve months ended December 31, 2016 vs December 31, 2015, Honeywell International reported revenue of $39,302 vs
$38,581 (up 1.9%), diluted earnings per share $6.20 vs $6.04 (up 2.7%), and dividends per share $2.45 vs $2.15 (up 14.0%).
To read the full Honeywell International Inc. (HON) report, download it here: http://Fundamental-Markets.com/register/?so=HON
-----------------------------------------
NEKTAR THERAPEUTICS (NKTR) REPORT OVERVIEW
Nektar's Recent Financial Performance
For the three months ended June 30, 2017 vs June 30, 2016, Nektar reported revenue of $34.6 vs $32.8 (up 5.5%)
and diluted earnings per share -$0.39 vs -$0.36. For the twelve months ended December 31, 2016 vs December 31, 2015, Nektar
reported revenue of $55.4 vs $40.2 (up 37.8%) and diluted earnings per share -$1.10 vs -$0.61.
To read the full Nektar Therapeutics (NKTR) report, download it here: http://Fundamental-Markets.com/register/?so=NKTR
-----------------------------------------
PDL BIOPHARMA, INC. (PDLI) REPORT OVERVIEW
PDL Biopharma, Inc.'s Recent Financial Performance
For the three months ended June 30, 2017 vs June 30, 2016, PDL Biopharma, Inc. reported revenue of $143.8 vs
$21.0 (up 584.8%) and diluted earnings per share $0.39 vs $0.03 (up 1200.0%). For the twelve months ended December 31, 2016 vs
December 31, 2015, PDL Biopharma, Inc. reported revenue of $244.3 vs $590.4 (down 58.6%), diluted earnings per share $0.39 vs $2.03
(down 80.8%).
To read the full PDL Biopharma, Inc. (PDLI) report, download it here: http://Fundamental-Markets.com/register/?so=PDLI
-----------------------------------------
INNOVIVA INC. (INVA) REPORT OVERVIEW
Innoviva's Recent Financial Performance
For the three months ended June 30, 2017 vs June 30, 2016, Innoviva reported revenue of $48.6 vs $33.3 (up
46.0%) and diluted earnings per share $0.21 vs $0.13 (up 61.5%). For the twelve months ended December 31, 2016 vs December 31,
2015, Innoviva reported revenue of $133.6 vs $54.0 (up 147.4%) and diluted earnings per share $0.53 vs -$0.16.
To read the full Innoviva, Inc. (INVA) report, download it here: http://Fundamental-Markets.com/register/?so=INVA
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world’s leading
brokerages for over a decade—and continue to be one of the best information sources for investors and investment professionals
worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA®
BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst®
(CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit
firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail
at compliance@fundamental-markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the
material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the
publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: andrew.duffie@fundamental-markets.com
© 2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a
partner network manager at partnership@fundamental-markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory
Authority, Inc.
